StemCells (STEM) Misses Q3 EPS by 2c

StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $883 million versus the consensus estimate of $220 million.

For earnings history and earnings-related data on StemCells (STEM) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Integra Resources raises Florida Canyon reserve 74%, lifts cost guid
• AMC Entertainment closes $200M stock offering, to retire 2027 notes